Expression of Wnt5a, Fzd3, and Fzd5 in non-melanoma skin cancer.<sup>1</sup> Celine Pourreyron Louise Reilly Charlotte Proby Andrey Panteleyev Colin Fleming Kathleen McLean Andrew P. South John Foerster 10.1371/journal.pone.0031827.t001 https://plos.figshare.com/articles/dataset/_Expression_of_Wnt5a_Fzd3_and_Fzd5_in_non_melanoma_skin_cancer_1_/348773 1<p>Immunohistochemistry of formaldehyde-fixed paraffin-embedded SCC (n = 12) and BCC (n = 9) samples was carried out as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031827#s2" target="_blank">Methods</a>.</p>2<p>Expression level was scored as “moderate” when staining intensity was comparable, as “strong” when staining was stronger, and as “low” when staining was weaker than that of epidermis present in the same section, respectively.</p> 2012-02-22 02:26:13 fzd5 non-melanoma